Trial
NCT02524119
LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Texas Southwestern Medical Center
Collaborators
Novartis Pharmaceuticals
Condition
Hepatocellular Carcinoma
Intervention
LEE011
Why stopped
This study was terminated after the sponsor withdrew our support
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-01